Acute erythroid leukemia with failed remission
Acute erythroid leukemia NOS
Acute erythroid leukemia
Erythroleukemia, fab m6
A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
A progressive, proliferative disease of blood cells, originating from immature erythroid cells.
Acute erythroid leukemia characterised by the presence of at least 50% erythroid precursors and at least 20% myeloblasts in the bone marrow.
Acute erythroid leukemia characterised by the presence of immature erythroid cells in the bone marrow at least 80% of the cellular component), without evidence of a significant myeloblastic cell population present.
An acute myeloid leukemia characterized by a predominant immature erythroid population. There are two subtypes recognized: erythroleukemia and pure erythroid leukemia. Severe anemia is a common symptom. This leukemia usually follows an aggressive clinical course. who, 2001)
Cancer of the blood-forming tissues in which large numbers of immature, abnormal red blood cells are found in the blood and bone marrow.
Myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
The progression of a myelodysplastic syndrome in which there is erythroid predominance into erythroleukemia m6a or erythroleukemia, erythroid/myeloid).
C94.00 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2023 edition of ICD-10-CM C94.00 became effective on October 1, 2022.
This is the American ICD-10-CM version of C94.00 – other international versions of ICD-10 C94.00 may differ.